Company Search:
Advanced Search
Sponsored Links
Medicamen Biotech Limited Company Snapshot
Medicamen Biotech Limited operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Medicamen Biotech Limited with three other companies in this sector in India: Parabolic Drugs Limited (2016 sales of 768.35 million Indian Rupees [US$11.92 million] ), Coral Laboratories Limited (770.16 million Indian Rupees [US$11.95 million] ), and Godavari Drugs Ltd (711.21 million Indian Rupees [US$11.03 million] ).

Sales Analysis. Medicamen Biotech Limited reported sales of 672.76 million Indian Rupees (US$10.43 million) for the fiscal year ending March of 2016. This represents a decrease of 13.5% versus 2015, when the company's sales were 777.94 million Indian Rupees.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Medicamen Biotech Limited
  Stock Performance Chart for Medicamen Biotech Limited
  Stock Data: Recent Stock Performance:
  Current Price (4/21/2017): 504.60
(Figures in Indian Rupees)
1 Week -5.0%   13 Weeks -2.3%  
4 Weeks 46.2%   52 Weeks 497.9%  
Medicamen Biotech Limited Key Data:
  Ticker: 531146 Country: India
  Exchanges: BOM Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 672,759,231
(Year Ending Jan 2017).
Employees: N/A
  Currency: Indian Rupees Market Cap: 5,307,688,588
  Fiscal Yr Ends: March Shares Outstanding: 10,518,606
  Share Type: Ordinary Closely Held Shares: 6,738,726
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.